JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooksey, R. C.
Right arrow Articles by Mahoney, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooksey, R. C.
Right arrow Articles by Mahoney, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2002, p. 1651-1655, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1651-1655.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Characterization of Mycobacterium tuberculosis Complex Isolates from the Cerebrospinal Fluid of Meningitis Patients at Six Fever Hospitals in Egypt

Robert C. Cooksey,1* Said H. Abbadi,1,{dagger} Charles L. Woodley,1 David Sikes,1 Momtaz Wasfy,2 Jack T. Crawford,1 and Frank Mahoney2

Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 U.S. Naval Medical Research Unit No. 3, Cairo, Egypt2

Received 10 December 2001/ Returned for modification 27 January 2002/ Accepted 5 February 2002

Mycobacterium tuberculosis complex isolates from cerebrospinal fluid of 67 meningitis patients were obtained from six fever hospitals in Egypt. One M. bovis and 66 M. tuberculosis isolates were identified by PCR-restriction fragment length polymorphism (RFLP) analysis of oxyR. Among the M. tuberculosis isolates, 53 unique strain types (with 3 to 16 copies of IS6110) were found by RFLP analyses. Nine clusters (eight with two isolates each and one with six isolates) were also found. Thirty-six spoligotypes, including at least 10 that have been previously reported from other countries, were also observed. Forty-one (62.1%) of the isolates were in spoligotype clusters, and 22 (33%) of the isolates were in RFLP clusters. Fifty-one of the isolates were susceptible in vitro to all of the antituberculosis drugs tested, 11 were monoresistant to capreomycin, rifampin, isoniazid (INH), pyrazinamide, or streptomycin (STR), 4 were resistant to STR and INH, and 1 was resistant to STR, INH, and ethambutol.


* Corresponding author. Mailing address: Tuberculosis/Mycobacteriology Branch, Centers for Disease Control and Prevention, Mail Stop F-08, Atlanta, GA 30333. Phone: (404) 639-1283. Fax: (404) 639-1287. E-mail: rcc1{at}cdc.gov.

{dagger} Present address: Department of Microbiology, Suez Canal University School of Medicine, Ismailia, Egypt.


Journal of Clinical Microbiology, May 2002, p. 1651-1655, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1651-1655.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.